Full Text View
Tabular View
Study Results
Related Studies
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
This study has been completed.
Study NCT00420745   Information provided by GlaxoSmithKline

First Received on January 9, 2007.   Last Updated on March 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rotavirus Vaccines
Additional conditions recognized in this trial
Adenovirus Infections, Human
Enteritis
Enterovirus Infections
Gastroenteritis
More general conditions related to this trial
Adenoviridae Infections
Digestive System Diseases
DNA Virus Infections
Gastrointestinal Diseases
Intestinal Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Rotarix™
Placebo
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services